Approval · Notice of Compliance 35197 · 2025
LEDAGA: Notice of Compliance 35197
Issued April 15, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35197
- Date
- April 15, 2025
- Company
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the drug substance. Ajout d'un site de fabrication ou d'un fabricant impliquant la fabrication de la substance médicamenteuse.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEDAGA | Not yet assigned | — |
Medicinal ingredients
- CHLORMETHINE HYDROCHLORIDE 160 MCG per G